Ethyl 2-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridinyl]sulfanyl]propanoate
C16H14ClF4N3O4S — CID 155591749
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 2-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridinyl]sulfanyl]propanoate
Ethyl 2-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridinyl]sulfanyl]propanoate (PubChem CID 155591749) has the molecular formula C16H14ClF4N3O4S and a molecular weight of 455.82 g/mol. Its IUPAC name is ethyl 2-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridinyl]sulfanyl]propanoate.
Molecular Properties
| Compound Name | Ethyl 2-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridinyl]sulfanyl]propanoate |
|---|---|
| PubChem CID | 155591749 |
| Molecular Formula | C16H14ClF4N3O4S |
| Molecular Weight | 455.82 g/mol |
| Exact Mass | 455.03 |
| IUPAC Name | ethyl 2-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridinyl]sulfanyl]propanoate |
| SMILES | CCOC(=O)C(C)Sc1nc(-n2c(=O)cc(C(F)(F)F)n(C)c2=O)c(F)cc1Cl |
| InChI | InChI=1S/C16H14ClF4N3O4S/c1-4-28-14(26)7(2)29-13-8(17)5-9(18)12(22-13)24-11(25)6-10(16(19,20)21)23(3)15(24)27/h5-7H,4H2,1-3H3 |
| InChIKey | XEDQPQAYJXFUIC-UHFFFAOYSA-N |
| XLogP | 2.79 |
| TPSA | 83.19 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 455.82 |
| LogP ≤ 5 | 2.79 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155591749 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.